These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35358712)

  • 1. Optical coherence tomography angiography in the evaluation of vascular patterns of ocular surface squamous neoplasia during topical medical treatment.
    Theotoka D; Liu Z; Wall S; Galor A; Al Bayyat GJ; Feuer W; Jianhua W; Karp CL
    Ocul Surf; 2022 Jul; 25():8-18. PubMed ID: 35358712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of optical coherence tomography angiography in the characterization of vascular network patterns of ocular surface squamous neoplasia.
    Liu Z; Karp CL; Galor A; Al Bayyat GJ; Jiang H; Wang J
    Ocul Surf; 2020 Oct; 18(4):926-935. PubMed ID: 32344147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term study of topical interferon α-2b eye drops as primary treatment of ocular surface squamous neoplasia.
    Sripawadkul W; Reyes-Capo D; Zein M; Wylegala A; Albayyat G; Galor A; Karp CL
    Ocul Surf; 2023 Apr; 28():108-114. PubMed ID: 36592780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra high-resolution anterior segment optical coherence tomography in the diagnosis and management of ocular surface squamous neoplasia.
    Thomas BJ; Galor A; Nanji AA; El Sayyad F; Wang J; Dubovy SR; Joag MG; Karp CL
    Ocul Surf; 2014 Jan; 12(1):46-58. PubMed ID: 24439046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical 1% 5-fluorouracil eye drops as primary treatment for ocular surface squamous neoplasia: Long-term follow-up study.
    Wylegala A; Sripawadkul W; Zein M; Alvarez OP; Al Bayyat G; Galor A; Karp CL
    Ocul Surf; 2023 Jan; 27():67-74. PubMed ID: 36476665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Topical 5-Fluorouracil and Interferon Alfa-2b as Primary Treatment Modalities for Ocular Surface Squamous Neoplasia.
    Venkateswaran N; Mercado C; Galor A; Karp CL
    Am J Ophthalmol; 2019 Mar; 199():216-222. PubMed ID: 30471241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical treatment for ocular surface squamous neoplasia.
    Monroy D; Serrano A; Galor A; Karp CL
    Eye (Lond); 2023 Apr; 37(5):885-893. PubMed ID: 36754986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic inflammation as a proposed risk factor for ocular surface squamous neoplasia.
    De Arrigunaga S; Wall S; Theotoka D; Friehmann A; Camacho M; Dubovy S; Galor A; Karp CL
    Ocul Surf; 2024 Jul; 33():1-10. PubMed ID: 38432640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular surface squamous neoplasia: angiographic characteristics and response to subconjunctival/perilesional 5-fluorouracil injections.
    Sun Y; Hua R
    Drug Des Devel Ther; 2019; 13():1323-1334. PubMed ID: 31118569
    [No Abstract]   [Full Text] [Related]  

  • 10. Anterior High-Resolution Optical Coherence Tomography in the Diagnosis and Therapeutic Monitoring of Ocular Surface Squamous Neoplasia.
    Li Y; Jin X; Zhang H
    J Vis Exp; 2024 Aug; (210):. PubMed ID: 39185872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra-high resolution optical coherence tomography for differentiation of ocular surface squamous neoplasia and pterygia.
    Kieval JZ; Karp CL; Abou Shousha M; Galor A; Hoffman RA; Dubovy SR; Wang J
    Ophthalmology; 2012 Mar; 119(3):481-6. PubMed ID: 22154538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Optical Coherence Tomography Comparison Between Ocular Surface Squamous Neoplasia and Squamous Metaplasia.
    Stevens SM; Reyes-Capo DP; Patel U; Choudhary A; Khzam RA; Tang V; Galor A; Karp CL; Dubovy S
    Cornea; 2023 Apr; 42(4):429-434. PubMed ID: 35439777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. It Is All About the Angle: A Clinical and Optical Coherence Tomography Comparison of Corneal Ocular Surface Squamous Neoplasia and Corneal Pannus.
    Huang JJ; Locatelli EVT; Huang JJ; De Arrigunaga S; Rao P; Dubovy S; Karp CL; Galor A
    Cornea; 2024 Oct; 43(10):1249-1256. PubMed ID: 37889526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of high-resolution anterior segment optical coherence tomography in the diagnosis and management of sub-clinical ocular surface squamous neoplasia.
    Tran AQ; Venkateswaran N; Galor A; Karp CL
    Eye Vis (Lond); 2019; 6():27. PubMed ID: 31463333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of high resolution optical coherence tomography in diagnosing ocular surface squamous neoplasia with coexisting ocular surface diseases.
    Atallah M; Joag M; Galor A; Amescua G; Nanji A; Wang J; Perez VL; Dubovy S; Karp CL
    Ocul Surf; 2017 Oct; 15(4):688-695. PubMed ID: 28347855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon Alfa 2b for Ocular Surface Squamous Neoplasia: Factors Influencing the Treatment Response.
    Kaliki S; Bejjanki KM; Desai A; Mohamed A
    Semin Ophthalmol; 2019; 34(7-8):465-472. PubMed ID: 31370766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of ocular surface squamous neoplasia in an Indian rural facility: a study of 38 eyes.
    Agarwal A; Ghose N; Rathi V; Khanna R; Kaliki S
    BMC Ophthalmol; 2024 Sep; 24(1):389. PubMed ID: 39227791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment.
    Leventer I; Singh H; Pashaee B; Raimondo CD; Khakh CK; Martin JL; Acharya B; Zhang Q; Lally SE; Shields CL
    Asia Pac J Ophthalmol (Phila); 2024; 13(2):100052. PubMed ID: 38521390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
    Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
    Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous regression of presumed ocular surface squamous neoplasia: A report of 8 cases.
    Vempuluru VS; Ghose N; Vithalani NM; Sultana S; Kaliki S
    Eur J Ophthalmol; 2022 Sep; 32(5):3029-3034. PubMed ID: 34747253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.